Literature DB >> 10323262

Regulation of vascular tone by UTP and UDP in isolated rat intrapulmonary arteries.

A Rubino1, L Ziabary, G Burnstock.   

Abstract

Vasoconstrictor and vasodilator responses of isolated rat intrapulmonary arteries to the pyrimidine nucleotides UTP and UDP were evaluated and compared with vascular responses to ATP and its analogues. UTP and UDP (1-500 microM) were equipotent in inducing concentration-dependent vasoconstriction, unaffected by the P2 receptor antagonists suramin (100 microM) and Reactive blue 2 (50 microM); ATP (10-500 microM) produced weaker vasoconstriction. UTP and UDP lacked vasodilator activity, while ATP and its analogue 2-methylthio ATP evoked endothelium-dependent vasodilatation. These results indicate that UTP and UDP evoke vasoconstriction of rat intrapulmonary arteries whereas ATP is predominantly a vasodilator at the same arteries. Furthermore, the pharmacological profile of the native UTP/UDP receptor differs from that of the known P2Y2, P2Y4 and P2Y6 recombinant receptors for pyrimidine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323262     DOI: 10.1016/s0014-2999(99)00150-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.

Authors:  Pieter-Jan D F Guns; András Korda; Herta M Crauwels; Tim Van Assche; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

2.  Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure.

Authors:  Eun Bok Baek; Hae Young Yoo; Su Jung Park; Hyang Sun Kim; Seong Deok Kim; Yung E Earm; Sung Joan Kim
Journal:  Pflugers Arch       Date:  2008-06-10       Impact factor: 3.657

3.  P2Y₂ receptor activation decreases blood pressure and increases renal Na⁺ excretion.

Authors:  Timo Rieg; Maria Gerasimova; José L Boyer; Paul A Insel; Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

4.  Novel excitatory effects of adenosine triphosphate on contractile and pacemaker activity in rabbit urethral smooth muscle.

Authors:  Eamonn Bradley; Sonia Kadima; Bernard Drumm; Mark A Hollywood; Keith D Thornbury; Noel G McHale; Gerard P Sergeant
Journal:  J Urol       Date:  2010-02       Impact factor: 7.450

5.  M-type K+ currents in rat cultured thoracolumbar sympathetic neurones and their role in uracil nucleotide-evoked noradrenaline release.

Authors:  W Nörenberg; I von Kügelgen; A Meyer; P Illes; K Starke
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Regional variation in P2 receptor expression in the rat pulmonary arterial circulation.

Authors:  K Chootip; K F Ness; Y Wang; A M Gurney; C Kennedy
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

7.  Amplification of the COX/TXS/TP receptor pathway enhances uridine diphosphate-induced contraction by advanced glycation end products in rat carotid arteries.

Authors:  Takayuki Matsumoto; Mihoka Kojima; Keisuke Takayanagi; Tomoki Katome; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2019-11-18       Impact factor: 3.657

8.  Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries.

Authors:  S J Rayment; M L Latif; V Ralevic; S P H Alexander
Journal:  Br J Pharmacol       Date:  2007-01-29       Impact factor: 8.739

9.  P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37.

Authors:  J A Dominguez Rieg; J M Burt; P Ruth; T Rieg
Journal:  Acta Physiol (Oxf)       Date:  2015-01-08       Impact factor: 6.311

10.  P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.

Authors:  Sonja Buvinic; René Briones; J Pablo Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.